CN101522056A - 老年人的长期喂养 - Google Patents
老年人的长期喂养 Download PDFInfo
- Publication number
- CN101522056A CN101522056A CNA2007800376342A CN200780037634A CN101522056A CN 101522056 A CN101522056 A CN 101522056A CN A2007800376342 A CNA2007800376342 A CN A2007800376342A CN 200780037634 A CN200780037634 A CN 200780037634A CN 101522056 A CN101522056 A CN 101522056A
- Authority
- CN
- China
- Prior art keywords
- product
- kilocalories
- per
- source
- nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007774 longterm Effects 0.000 title claims abstract description 23
- 235000016709 nutrition Nutrition 0.000 claims abstract description 45
- 230000035764 nutrition Effects 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 41
- 239000000203 mixture Substances 0.000 claims abstract description 27
- 235000018102 proteins Nutrition 0.000 claims description 19
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 150000001720 carbohydrates Chemical class 0.000 claims description 17
- 235000014633 carbohydrates Nutrition 0.000 claims description 17
- 150000002632 lipids Chemical class 0.000 claims description 16
- 239000000835 fiber Substances 0.000 claims description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 12
- 229930091371 Fructose Natural products 0.000 claims description 10
- 239000005715 Fructose Substances 0.000 claims description 10
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 9
- 108010046377 Whey Proteins Proteins 0.000 claims description 9
- 102000007544 Whey Proteins Human genes 0.000 claims description 9
- 239000011651 chromium Substances 0.000 claims description 9
- 229910052804 chromium Inorganic materials 0.000 claims description 9
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 7
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000005862 Whey Substances 0.000 claims description 7
- 239000005018 casein Substances 0.000 claims description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical group NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 7
- 235000021240 caseins Nutrition 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 235000013325 dietary fiber Nutrition 0.000 claims description 7
- 235000012680 lutein Nutrition 0.000 claims description 7
- 239000001656 lutein Substances 0.000 claims description 7
- 229960005375 lutein Drugs 0.000 claims description 7
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 7
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 7
- 235000012661 lycopene Nutrition 0.000 claims description 7
- 239000001751 lycopene Substances 0.000 claims description 7
- 229960004999 lycopene Drugs 0.000 claims description 7
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 7
- 229940035034 maltodextrin Drugs 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 150000005846 sugar alcohols Chemical class 0.000 claims description 7
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 7
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 7
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 7
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 6
- 235000013734 beta-carotene Nutrition 0.000 claims description 6
- 239000011648 beta-carotene Substances 0.000 claims description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 6
- 229960002747 betacarotene Drugs 0.000 claims description 6
- 229960004203 carnitine Drugs 0.000 claims description 6
- 229960001231 choline Drugs 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 6
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 6
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 6
- 229960003080 taurine Drugs 0.000 claims description 6
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 230000001684 chronic effect Effects 0.000 claims description 5
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 4
- 235000021081 unsaturated fats Nutrition 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000013406 prebiotics Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 5
- 108010076119 Caseins Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 4
- 235000021590 normal diet Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002641 glycemic effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 208000014829 head and neck neoplasm Diseases 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- -1 lycopene (tomato) Chemical class 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明提供了为需要长期和管饲营养的患者提供相同营养的方法。更具体而言，本发明提供了为老年患者提供长期营养的方法和组合物。
Description
发明背景
本申请涉及营养。更具体而言，本发明涉及临床营养。
由于多种疾病、创伤、和并发症，患者可能无法通过口摄取食物，例如进食来获得必需的营养。因此，经肠内或肠胃外提供临床营养已广为人知。已开发了多种不同制剂来提供此类临床营养。
甚至就典型的肠内营养产品而言，这些产品设计为短期使用，通常为10到24天。在此方面，产品通常提供基本营养成分以向具有急性病状的患者在他们住院期间提供必需营养。虽然这些产品适合这种短期使用，但却不曾必要地将它们设计用于患者的长期喂养。随着医学进步，导致预期寿命增长并且疾病治疗变得更好，许多个体可以从为提供长期肠内营养而设计的产品中受益。
发明概述
本发明提供向需要长期管饲营养的患者提供长期管饲营养的方法。更具体而言，本发明提供为老年患者提供长期管饲营养的方法和组合物。
为此，在实施方案中，本发明提供为老年患者提供管饲营养的方法，所述方法包括步骤：经导管长期施用营养产品至少每天一次，所述营养产品包含：按产品热焓计包含14％至20％的蛋白质来源；按产品热焓计包含10％至50％的糖类来源；按产品热焓计包含30％至45％的脂类来源；每升产品中提供10至25克的膳食纤维来源；和每100千卡产品8.0至18.0微克铬。
根据所述方法，在实施方案中，按重量计脂类可包含40到60％的单不饱和脂肪(MUFA)。在实施方案中，所述产品每100千卡包含不超过1.1克的饱和脂肪酸(SFA)，且按脂类重量计所述产品包含0.4％至2.0％的二十碳五烯酸(EPA)。蛋白质来源可选自酪蛋白、乳清和大豆。糖类可选自果糖、糖醇、淀粉、糊精和麦芽糖糊精。
根据所述方法，产品可包含其它成分。例如，每100千卡所述产品可包含至少：30mg胆碱；4.0mg牛磺酸；和/或3.0mg肉碱。此外，每100千卡所述产品可包含至少：0.1mg β-胡萝卜素；0.2mg番茄红素；和/或0.05mg叶黄素。
在所述方法的实施方案中，能量密度为0.8至1.3千卡/ml。如需要，所述产品包含益生元，并提供可溶性及不溶性纤维。按重量计至少25％的纤维是可溶性的。
在另一个实施方案中，本发明提供了为老年患者提供营养的方法，所述方法包括步骤：经导管长期施用组合物至少每天一次，所述组合物包含：蛋白质来源；脂肪来源；由糖类来源提供的不超过44％的组合物能量；包含按重量计至少25％可溶性纤维的膳食纤维来源；每100千卡产品至少8.0微克铬；维生素D；和钙。
在所述方法的实施方案中，每100千卡中维生素D包含至少0.5微克且每100千卡中钙包含至少35mg。
在所述方法的实施方案中，所述蛋白质来源选自酪蛋白、乳清和大豆且所述糖类选自果糖、糖醇、淀粉、糊精和麦芽糖糊精。
更进一步，根据本发明，提供用于提供长期管饲营养的组合物，所述组合物包含：按产品热焓计包含14％至20％的蛋白质来源；按产品热焓计包含10％至50％的糖类来源；按产品热焓计包含30％至45％的脂类来源；每升产品中提供10至25克且包含可溶性及不溶性纤维的膳食纤维来源，其中按重量计至少25％的纤维是可溶性的；每100千卡产品中8.0至18.0微克铬。
对产品的许多变更和添加是可能的。例如，脂类可包含按重量计40％至60％的单不饱和脂肪，每100千卡不超过1.1克饱和脂肪酸，和按脂类重量计0.4％至2.0％的二十碳五烯酸。所述蛋白质来源可选自酪蛋白、乳清和大豆且所述糖类可选自果糖、糖醇、淀粉、糊精和麦芽糖糊精。在实施方案中，每100千卡所述产品包含至少：30mg胆碱；4.0mg牛磺酸；和3.0mg肉碱。在另一个实施方案中，每100千卡所述产品包含至少：0.1mgβ-胡萝卜素；0.2mg番茄红素；和0.05mg叶黄素。
本发明的优点在于提供改善的肠内营养产品。
此外，本发明的优点在于提供用于提供肠内营养的改良方法。
此外，本发明的优点在于提供用于为老年患者提供长期管饲营养的组合物。
此外，本发明的优点在于提供为老年患者提供长期管饲营养的方法。
此处描述了额外的特征和优点，并在以下详细描述中将是显而易见的。
发明详述
本发明涉及临床营养。更具体而言，本发明涉及为老年患者提供长期管饲营养。如此处所用，术语“长期”指超过一个月(30天)。如此处所用，术语“管饲”指经喂食导管为患者提供产品，所述喂食导管与患者消化道的一部分接合，例如，鼻饲导管或经皮内镜胃造瘘术导管。申请人因此提交标题为“提供长期营养的方法”的专利申请，所述申请公开了多种长期肠内营养配方和基于以上的商业方法，其公开内容特此引入作为参考。
长期管饲营养产品优选设计用于老年患者。如此处所用，术语“老年患者”指不能通过正常饮食摄取营养但代谢正常(即未患代谢疾病)的65岁或65岁以上的成年患者。这类患者先前可能曾经历过头部或颈部癌症手术而消化道不完整或不能吞咽，可能颈部曾受到损伤而使得他或她不能吞咽或因例如中风引起的神经学损伤而不能吞咽，或可能患有如阿尔茨海默氏病、帕金森病、吞咽咽困难或CVA疾病。如此处所用，术语“正常饮食”指通过进食(即使用一个人的嘴，不使用任何喂养导管或肠胃外给养)摄取至少基本上全部营养。
在本发明的组合物中，已进行尝试来优化喂食制剂的老年患者体内的血糖应答。高血糖的重复性发作是老年人肠道喂养的主要困难。这对于在余生中可能需要长期管饲营养的老年患者而言尤为严重。高血糖可以加重被认为与许多衰老症状相关的慢性低水平炎症。例如，高血糖的反复发作可能与血管内皮的炎症相关，导致血管缩窄。这可导致心血管疾病和与此相关的问题。类似地，尿体积会增加，导致无机物的过量损失和肾脏相应的负荷。
因此，根据本发明，在至少一个实施方案中，所述制剂能够通过维持血糖稳态来维持长期管饲营养的老年患者的代谢状态。为此，设计所述组合物来降低胰岛素抗性和/或调节葡萄糖反应。在实施方案中，设计所述制剂来长期提供每天1500ml必需的营养。
优选地，所述组合物提供供应14％至20％产品总热焓的蛋白质来源。可使用任何高品质蛋白质来源，或其混合物，以提供平衡的必需氨基酸谱。实例包括酪蛋白、乳清和大豆蛋白质。蛋白质可为完整蛋白质或部分水解的蛋白质。如需要可添加游离氨基酸。优选地，按重量计至少50％的蛋白质是乳清蛋白质。在实施方案中，利用60％乳清蛋白质和40％大豆蛋白质的混合物。
优选地，糖类来源提供10％至50％的产品总热焓。在优选的实施方案中，它提供少于45％的总热焓。选择所述糖类成分来优选提供低血糖应答。合适的糖类为果糖、糖醇如山梨醇和木糖醇、淀粉、糊精、麦芽糖糊精和其混合物。
优选地，脂类来源提供30％至45％的总热焓，其中按所述脂类重量计40％至60％为单不饱和脂肪酸(MUFA)。可使用膳食脂类的任何合适混合物如饱和脂肪酸(SFA)、MUFA、多不饱和脂肪酸(PUFA)和中链甘油三酯(MCT)。优选地，所述饱和脂肪酸不超过1.1g/100千卡。优选地，按所述脂类重量计0.4％至2％为二十碳五烯酸。
可向产品中添加额外的物质。例如，每100千卡胆碱可以以至少30mg的水平存在，牛磺酸以至少5.0mg的水平存在，且肉碱以至少3.0mg的水平存在。关于植物营养物，其每100千卡可按如下量存在：至少0.1mgβ-胡萝卜素、至少0.2mg番茄红素、和至少0.05mg叶黄素。在实施方案中，产品的能量密度介于0.8至1.3千卡/ml间。
根据本发明的配方，通过提供降低的糖类摄入，和添加果糖、纤维和铬，配方有助于维持血糖稳态。此外，该配方能够处理在患者群中葡萄糖不耐受的盛行。
在发明的实施方案中使用果糖。果糖运进细胞而无需任何胰岛素介入。因此，它是代替葡萄糖的极好的能量来源。此外，果糖促进葡萄糖的肝脏利用。这两种机制帮助避免过度的餐后高血糖。
由于铬激活葡萄糖的氧化，因此在组合物中使用铬是有益的。它限制对葡萄糖的不耐受并降低对胰岛素的需要。
使用改良纤维调节葡萄糖的吸收。这限制血糖峰值。此外，维生素D摄入量是高的，以便维持骨量储备。
如上指出，本发明提供为长期使用而优化和/或改良的方法及产品。在实施方案中，为在医院环境之外的患者提供这些产品。例如，可在疗养院、外部患者护理中心、或甚至患者家中提供所述产品。优选地，将营养产品包装于塑料袋中。多种此类袋子是公知的，例如，500ml、1000ml和1500ml袋子是本领域已知的。然而，应指出任何合适的容器均可用于容纳该营养产品。在实施方案中，设计产品用于以每天1500ml提供必需营养，尽管本领域技术人员将理解该水平的变化是可能的。
在实施方案中，专门设计营养产品使得它们可提供完整的长期营养，并尝试提供与进食正常膳食的人摄入的相同的大量营养物和微量营养物。因此在实施方案中，配方模拟此处所指的每天5/8。如此处所用，术语“每天5/8”指政府对消费者每天进食5至8份水果和蔬菜的指导方针。因此，在实施方案中设计产品使得在可能程度上它们通过提供在水果和蔬菜中发现的微量营养物和植物营养物来尝试模拟不需要管饲产品的个体优选摄入的正常饮食。在实施方案中，本发明提供基于尝试模拟每天5/8设计长期肠内营养产品的方法。通过提供此类营养产品，可维持患者的抗氧化状态及代谢状态。目标是在可能程度上使这些患者处于与进食均衡膳食的相同年龄的完全健康个体相当的状态。
已发现植物营养物提供如下特征：抗氧化、抗炎症、解毒、抗癌、预防动脉粥样硬化、缓解代谢综合征并预防骨质损失。为获得必需的植物营养物，本发明的组合物可包含一种或多种类胡萝卜素如番茄红素(番茄)、B-胡萝卜素(胡萝卜、菠菜、番茄)、叶黄素(菠菜)、B-隐黄素、维生素如混合的生育酚(油和坚果)和维生素C(橙子)；和多酚类如儿茶素(绿茶)。
优选地，产品包含必需营养组分以在长期基础上为患者提供完全营养。在这方面，所述产品包含：蛋白质、糖类、脂肪、维生素和矿物质以及其它可能的成分。在实施方案中，所述产品基本上(如果不是完全地)满足至少某些政府要求。如此处使用，“政府要求”指来自以下政府中任何一个的任何建议：美国，通常为USRDA；德国，通常为德国RDA；和法国，通常为法国RDA。在实施方案中，所述营养产品满足或超过政府要求中的至少一种。
通过实施例并且非限定，现在给出本发明的实施例。
实施例1-老年人产品
实施例2-老年人产品
根据本发明的实施方案，可在需要时至少每天一次长期向不能进食正常饮食的老年患者提供实施例1或2的制剂。
应理解对此处描述的目前优选实施方案的多种改变和修饰对于本领域技术人员将是显而易见的。可在不背离本主题的精神和范围及不减少其预期优点的情况下进行此类改变和修饰。因此旨在通过附带的权利要求涵盖此类改变和修饰。
Claims (30)
1.向老年患者提供管饲营养的方法，所述方法包括步骤：通过导管每天一次向老年患者长期施用营养产品，所述营养产品包含：按所述产品热焓计包含14％至20％的蛋白质来源；按所述产品热焓计包含10％至50％的糖类来源；按所述产品热焓计包含30％至45％的脂类来源；每升所述产品中提供10至25克的膳食纤维来源；和每100千卡所述产品中8.0至18.0微克铬。
2.权利要求1的方法，其中所述脂类包含按重量计40％至60％的单不饱和脂肪。
3.权利要求1的方法，其中按重量计至少25％的所述纤维是可溶性的。
4.权利要求1的方法，其中所述蛋白质来源选自酪蛋白、乳清和大豆。
5.权利要求1的方法，其中所述糖类选自果糖、糖醇、淀粉、糊精和麦芽糖糊精。
6.权利要求1的方法，其中所述产品每100千卡包含不超过1.1克饱和脂肪酸。
7.权利要求1的方法，其中所述产品包含按脂类重量计0.4％至2.0％的二十碳五烯酸。
8.权利要求1的方法，其中所述产品每100千卡包含至少：
30mg胆碱；
5.0mg牛磺酸；和
3.0mg肉碱。
9.权利要求1的方法，其中所述产品每100千卡包含下列的至少一种或多种：
0.1mg β-胡萝卜素；
0.2mg番茄红素；和
0.05mg叶黄素。
10.权利要求1的方法，其中所述能量密度为0.8至1.3千卡/ml。
11.权利要求1的方法，其中所述膳食纤维来源提供可溶性和不溶性纤维。
12.权利要求1的方法，其中所述产品包含益生元。
13.向老年患者提供营养的方法，所述方法包括步骤：至少每天一次通过导管长期施用组合物，所述组合物包含：蛋白质来源；脂肪来源；通过糖类来源提供的不超过所述组合物44％的能量；包含按重量计至少25％可溶性纤维的膳食纤维来源；每100千卡产品至少8.0微克铬；维生素D；和钙。
14.权利要求13的方法，其中每100千卡包含至少0.5微克维生素D。
15.权利要求13的方法，其中每100千卡包含至少35mg钙。
16.权利要求13的方法，其中所述蛋白质来源选自酪蛋白、乳清和大豆。
17.权利要求13的方法，其中所述糖类选自果糖、糖醇、淀粉、糊精和麦芽糖糊精。
18.权利要求13的方法，其中所述产品每100千卡包含不超过1.1克饱和脂肪酸。
19.权利要求13的方法，其中所述产品每100千卡包含至少：
30mg胆碱；
5.0mg牛磺酸；和
3.0mg肉碱。
20.权利要求13的方法，其中所述产品每100千卡包含至少：
0.1mg β-胡萝卜素；
0.2mg番茄红素；和
0.05mg叶黄素。
21.权利要求13的方法，其中所述能量密度为0.8至1.3千卡/ml。
22.用于提供长期管饲营养的组合物，所述组合物包含：按所述产品热焓计包含14％至20％的蛋白质来源；按所述产品热焓计包含10％至50％的糖类来源；按所述产品热焓计包含30％至45％的脂类来源；每升所述产品提供10至25克的膳食纤维来源，且包含可溶性及不溶性纤维，其中按所述纤维重量计至少25％是可溶性的；每100千卡所述产品中8.0至18.0微克铬；所述产品包含足够的矿物质和维生素以满足政府规定。
23.权利要求22的产品，其中所述脂类包含按重量计40％至60％的单不饱和脂肪。
24.权利要求22的产品，其中所述蛋白质来源选自酪蛋白、乳清和大豆。
25.权利要求22的产品，其中所述糖类选自果糖、糖醇、淀粉、糊精和麦芽糖糊精。
26.权利要求22的产品，其每100千卡包含不超过1.1克饱和脂肪酸。
27.权利要求22的产品，其包含按所述脂类重量计0.4％至2.0％的二十碳五烯酸。
28.权利要求22的产品，其每100千卡包含至少：
30mg胆碱；
5.0mg牛磺酸；和
3.0mg肉碱。
29.权利要求22的产品，其每100千卡包含至少：
0.1mg β-胡萝卜素；
0.2mg番茄红素；和
0.05mg叶黄素。
30.权利要求22的产品，其中所述能量密度为0.8至1.3千卡/ml。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86215606P | 2006-10-19 | 2006-10-19 | |
| US60/862,156 | 2006-10-19 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310460015.1A Division CN103494196A (zh) | 2006-10-19 | 2007-10-17 | 老年人的长期喂养 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101522056A true CN101522056A (zh) | 2009-09-02 |
Family
ID=39185934
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007800376342A Pending CN101522056A (zh) | 2006-10-19 | 2007-10-17 | 老年人的长期喂养 |
| CN201310460015.1A Pending CN103494196A (zh) | 2006-10-19 | 2007-10-17 | 老年人的长期喂养 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310460015.1A Pending CN103494196A (zh) | 2006-10-19 | 2007-10-17 | 老年人的长期喂养 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20100094246A1 (zh) |
| EP (1) | EP2081449A2 (zh) |
| JP (2) | JP2010513226A (zh) |
| CN (2) | CN101522056A (zh) |
| AU (1) | AU2007312284B2 (zh) |
| BR (1) | BRPI0717410A2 (zh) |
| CA (1) | CA2664139C (zh) |
| CL (1) | CL2007003018A1 (zh) |
| CO (1) | CO6160277A2 (zh) |
| IL (1) | IL197475A0 (zh) |
| MX (1) | MX2009003239A (zh) |
| MY (1) | MY148276A (zh) |
| RU (1) | RU2406411C1 (zh) |
| WO (1) | WO2008046865A2 (zh) |
| ZA (1) | ZA200903406B (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366105A (zh) * | 2011-10-29 | 2012-03-07 | 山西振东五和健康食品股份有限公司 | 一种适用于中老年女性机能维持的食品 |
| CN102753027A (zh) * | 2009-12-07 | 2012-10-24 | N·V·努特里奇亚 | 平衡脂肪组合物及其在适合肠饲的液体营养组合物中的用途 |
| CN105747218A (zh) * | 2010-06-28 | 2016-07-13 | 雀巢产品技术援助有限公司 | 低热量、高蛋白质营养组合物及其应用方法 |
| CN111838321A (zh) * | 2020-08-18 | 2020-10-30 | 青岛大学 | 一种含叶黄素和益生元的老年营养包及其制备方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI492744B (zh) | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| JP2015513894A (ja) * | 2012-03-13 | 2015-05-18 | サッポロ・ホールディングス・リミテッド | 栄養学的にバランスの取れた食料品又は飲料品 |
| US20190029304A1 (en) * | 2016-01-25 | 2019-01-31 | Archer Daniels Midland Company | Improved pulse processing and products produced therefrom |
| CN110584093A (zh) * | 2019-08-08 | 2019-12-20 | 田伟盟 | 一种老年鼻饲患者匀浆膳 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686429A (en) * | 1995-01-13 | 1997-11-11 | Nestec Ltd | Method for providing nutrition to elderly patients |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704111A (en) * | 1983-04-22 | 1987-11-03 | Moss James P | Nasogastric feeding tube |
| US5017193A (en) * | 1988-09-26 | 1991-05-21 | Tri-State Hospital Supply Corp. | Infant feeding device |
| US5104677A (en) | 1991-06-27 | 1992-04-14 | Abbott Laboratories | Liquid nutritional product |
| US5403290A (en) * | 1992-04-20 | 1995-04-04 | Noble; Lisa W. | Gastric adapter/stopcock |
| JP2896375B2 (ja) * | 1993-03-08 | 1999-05-31 | 辛一 酒井 | 健康食品として優れたマヨネ−ズソ−スの製造法 |
| US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
| US5460603A (en) * | 1993-04-08 | 1995-10-24 | Massachusetts Institute Of Technology | Method and apparatus for preventing back flow in gastroenterological feeding system |
| US5700782A (en) * | 1993-05-28 | 1997-12-23 | Abbott Laboratories | Enteral nutritional product |
| CA2162042C (en) * | 1993-05-28 | 1999-02-23 | Frederick Oliver Cope | Enteral nutritional product |
| US5531681A (en) * | 1995-01-13 | 1996-07-02 | Abbott Laboratories | Apparatus for altering composition of nutritional product during enteral tube feeding |
| ES2123903T5 (es) * | 1995-08-04 | 2011-02-22 | N.V. Nutricia | Composición nutritiva conteniendo fibra. |
| US5985339A (en) * | 1996-11-22 | 1999-11-16 | Kamarei; A. Reza | Refrigeration-shelf-stable ready-to-drink complete nutritional compositions and products |
| DE19838636A1 (de) * | 1998-08-26 | 2000-03-02 | Basf Ag | Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein |
| US6355609B1 (en) * | 1999-04-14 | 2002-03-12 | Nestec S.A. | Methods for stabilizing liquid nutritional products and products so stabilized |
| EP1090636A1 (en) * | 1999-09-13 | 2001-04-11 | Société des Produits Nestlé S.A. | High lipid diet |
| JP2001316274A (ja) * | 2000-05-08 | 2001-11-13 | Asahi Kasei Corp | 経管栄養剤およびその製造方法 |
| US6989161B2 (en) * | 2000-06-12 | 2006-01-24 | Access Business Group International Llc | Phytonutrient nutritional supplement |
| EP1352652A4 (en) * | 2000-11-16 | 2004-10-06 | Morinaga Milk Industry Co Ltd | FAT COMPOSITION FOR ORAL OR ENTERAL ADMINISTRATION AND HEXACOSIC ACID INHIBITORS |
| JP2004515508A (ja) * | 2000-12-16 | 2004-05-27 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 化合物の健康促進組成物 |
| DE10109798A1 (de) * | 2001-03-01 | 2002-09-12 | Aventis Pharma Gmbh | Gesundheitsfördernde Zusammensetzung von Verbindungen |
| US6864242B2 (en) * | 2001-03-05 | 2005-03-08 | Stephen P. Ernest | Enteral formulation |
| US20020198502A1 (en) * | 2001-06-21 | 2002-12-26 | Luke Vohsing | Medical occlusion prevention apparatus and method |
| US20030104033A1 (en) * | 2001-07-13 | 2003-06-05 | Lai Chon-Si | Enteral formulations |
| MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
| US20070042019A1 (en) * | 2003-05-22 | 2007-02-22 | N.V. Nutricia | Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| CA2542652C (en) * | 2003-10-16 | 2014-05-13 | Nestec S.A. | Nutritional composition against side effects of chemotherapy or radiotherapy |
| US7090879B2 (en) * | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
| JP2005261384A (ja) * | 2004-03-22 | 2005-09-29 | Yasuko Morita | クルミ和え衣及びクルミ豆腐 |
| JP2006149371A (ja) * | 2004-08-24 | 2006-06-15 | Asama Chemical Co Ltd | 乳清タンパク食品 |
| KR101075816B1 (ko) * | 2004-09-22 | 2011-10-25 | 아지노모토 가부시키가이샤 | 종합 경장 영양 조성물 |
| JP2006094740A (ja) * | 2004-09-29 | 2006-04-13 | Asama Chemical Co Ltd | 乳清タンパク食品 |
| JP2006230346A (ja) * | 2005-02-28 | 2006-09-07 | Asama Chemical Co Ltd | 分散性の改善された乳由来のタンパク組成物 |
| JP2006104147A (ja) * | 2004-10-07 | 2006-04-20 | Otsuka Pharmaceut Factory Inc | 経口・経腸栄養組成物 |
| JP2006131611A (ja) * | 2004-10-07 | 2006-05-25 | Otsuka Pharmaceut Factory Inc | 骨代謝・たんぱく質代謝改善用栄養組成物 |
| CN101528066A (zh) * | 2006-10-19 | 2009-09-09 | 雀巢产品技术援助有限公司 | 癌症患者的长期喂饲 |
| DK2081597T3 (da) * | 2006-10-19 | 2012-07-23 | Nestec Sa | Lang-tids enteral føde til opretholdelse |
| JP2010507157A (ja) * | 2006-10-19 | 2010-03-04 | ネステク ソシエテ アノニム | 長期栄養を供給する方法 |
-
2007
- 2007-10-17 US US12/444,936 patent/US20100094246A1/en not_active Abandoned
- 2007-10-17 BR BRPI0717410-1A2A patent/BRPI0717410A2/pt not_active IP Right Cessation
- 2007-10-17 CA CA2664139A patent/CA2664139C/en not_active Expired - Fee Related
- 2007-10-17 EP EP07821463A patent/EP2081449A2/en not_active Withdrawn
- 2007-10-17 MX MX2009003239A patent/MX2009003239A/es active IP Right Grant
- 2007-10-17 CN CNA2007800376342A patent/CN101522056A/zh active Pending
- 2007-10-17 JP JP2009532799A patent/JP2010513226A/ja active Pending
- 2007-10-17 WO PCT/EP2007/061098 patent/WO2008046865A2/en active Application Filing
- 2007-10-17 AU AU2007312284A patent/AU2007312284B2/en not_active Ceased
- 2007-10-17 RU RU2009118587/13A patent/RU2406411C1/ru not_active IP Right Cessation
- 2007-10-17 MY MYPI20091014A patent/MY148276A/en unknown
- 2007-10-17 CN CN201310460015.1A patent/CN103494196A/zh active Pending
- 2007-10-19 CL CL2007003018A patent/CL2007003018A1/es unknown
-
2009
- 2009-03-08 IL IL197475A patent/IL197475A0/en unknown
- 2009-03-20 CO CO09029376A patent/CO6160277A2/es unknown
- 2009-05-18 ZA ZA200903406A patent/ZA200903406B/xx unknown
-
2013
- 2013-04-10 JP JP2013082097A patent/JP6096571B2/ja not_active Expired - Fee Related
- 2013-06-10 US US13/914,200 patent/US20130296234A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686429A (en) * | 1995-01-13 | 1997-11-11 | Nestec Ltd | Method for providing nutrition to elderly patients |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102753027A (zh) * | 2009-12-07 | 2012-10-24 | N·V·努特里奇亚 | 平衡脂肪组合物及其在适合肠饲的液体营养组合物中的用途 |
| CN102753027B (zh) * | 2009-12-07 | 2014-12-17 | N·V·努特里奇亚 | 平衡脂肪组合物及其在适合肠饲的液体营养组合物中的用途 |
| CN105747218A (zh) * | 2010-06-28 | 2016-07-13 | 雀巢产品技术援助有限公司 | 低热量、高蛋白质营养组合物及其应用方法 |
| CN102366105A (zh) * | 2011-10-29 | 2012-03-07 | 山西振东五和健康食品股份有限公司 | 一种适用于中老年女性机能维持的食品 |
| CN102366105B (zh) * | 2011-10-29 | 2012-12-05 | 山西振东五和健康食品股份有限公司 | 一种适用于中老年女性机能维持的食品 |
| CN111838321A (zh) * | 2020-08-18 | 2020-10-30 | 青岛大学 | 一种含叶黄素和益生元的老年营养包及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200903406B (en) | 2010-07-28 |
| BRPI0717410A2 (pt) | 2013-11-12 |
| CL2007003018A1 (es) | 2009-01-23 |
| IL197475A0 (en) | 2009-12-24 |
| JP6096571B2 (ja) | 2017-03-15 |
| JP2013166767A (ja) | 2013-08-29 |
| MX2009003239A (es) | 2009-04-08 |
| US20100094246A1 (en) | 2010-04-15 |
| RU2406411C1 (ru) | 2010-12-20 |
| AU2007312284B2 (en) | 2011-03-03 |
| WO2008046865A2 (en) | 2008-04-24 |
| CN103494196A (zh) | 2014-01-08 |
| EP2081449A2 (en) | 2009-07-29 |
| WO2008046865A3 (en) | 2008-12-11 |
| AU2007312284A1 (en) | 2008-04-24 |
| US20130296234A1 (en) | 2013-11-07 |
| CO6160277A2 (es) | 2010-05-20 |
| MY148276A (en) | 2013-03-29 |
| CA2664139A1 (en) | 2008-04-24 |
| JP2010513226A (ja) | 2010-04-30 |
| CA2664139C (en) | 2013-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101522056A (zh) | 老年人的长期喂养 | |
| CN101522220B (zh) | 一种肠内营养产品 | |
| CN101325882B (zh) | 包含长链多不饱和脂肪酸的营养补充剂 | |
| US5968896A (en) | Nutritional supplement for preoperative feeding | |
| AU2007312216B2 (en) | Long-term feed - cancer patient | |
| CN104853621A (zh) | 使用人乳寡糖用于调节炎症的营养制剂 | |
| Ho et al. | Trend of nutritional support in preterm infants | |
| EP2380582B1 (en) | Low-concentration nutritional composition | |
| JP2019140952A (ja) | 経口摂取用栄養調整食品 | |
| WO2021053447A1 (en) | Nutrition supplement for cancer patients | |
| MX2008007189A (es) | Suplemento nutricional que contieneacidos grasos poliinsaturados de cadena-larga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1135572 Country of ref document: HK |
|
| CI01 | Publication of corrected invention patent application |
Correction item: Second inventor Correct: Murbach Francois False: Murbach Francois Number: 35 Volume: 25 |
|
| CI02 | Correction of invention patent application |
Correction item: Second inventor Correct: Murbach Francois False: Murbach Francois Number: 35 Page: The title page Volume: 25 |
|
| ERR | Gazette correction |
Free format text: CORRECT: THE SECOND INVENTOR; FROM: FRANCOIS DERBACH TO: FRANCOIS MURBACH |
|
| RECT | Rectification | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090902 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1135572 Country of ref document: HK |